130 related articles for article (PubMed ID: 37086843)
21. Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI?
Capogrosso P; Vertosick EA; Benfante NE; Sjoberg DD; Vickers AJ; Eastham JA
Clin Genitourin Cancer; 2019 Aug; 17(4):e745-e750. PubMed ID: 31201051
[TBL] [Abstract][Full Text] [Related]
22. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
[TBL] [Abstract][Full Text] [Related]
23. Comparison of multiparametric MRI-based and transrectal ultrasound-based preplans with intraoperative ultrasound-based planning for low dose rate interstitial prostate seed implantation.
Fredman ET; Traughber BJ; Gross A; Podder T; Colussi V; Vinkler R; Machtay M; Ellis RJ
J Appl Clin Med Phys; 2019 Jun; 20(6):31-38. PubMed ID: 31004396
[TBL] [Abstract][Full Text] [Related]
24. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
25. Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
Meijer D; van Leeuwen PJ; Donswijk ML; Boellaard TN; Schoots IG; van der Poel HG; Hendrikse HN; Oprea-Lager DE; Vis AN
BJU Int; 2022 Jan; 129(1):54-62. PubMed ID: 34028165
[TBL] [Abstract][Full Text] [Related]
26. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
Barletta F; Stabile A; Mazzone E; Brembilla G; Sorce G; Pellegrino F; Scuderi S; Cannoletta D; Cirulli GO; Cucchiara V; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
Urol Oncol; 2022 Mar; 40(3):103.e17-103.e24. PubMed ID: 34688534
[TBL] [Abstract][Full Text] [Related]
27. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer.
Duque-Santana V; Diaz-Gavela A; Recio M; Guerrero LL; Peña M; Sanchez S; López-Campos F; Thuissard IJ; Andreu C; Sanz-Rosa D; Achard V; Gómez-Iturriaga A; Molina Y; Del Cerro Peñalver E; Couñago F
World J Urol; 2023 Dec; 41(12):3829-3838. PubMed ID: 37966505
[TBL] [Abstract][Full Text] [Related]
28. A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy.
Smith CW; Hoover D; Surry K; D'Souza D; Cool DW; Kassam Z; Bastian-Jordan M; Gomez JA; Moussa M; Chin J; Pautler S; Bauman GS; Ward AD
Brachytherapy; 2021; 20(3):601-610. PubMed ID: 33648893
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer.
Rayn K; Deutsch I; Jeffers B; Lee A; Lavrova E; Gallitto M; Mayeda M; Hwang M; Yu J; Spina C; Koutcher L
Adv Radiat Oncol; 2024 Mar; 9(3):101408. PubMed ID: 38304110
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
31. Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology.
Smith CW; Marcus T; Hoover D; Surry K; D'Souza D; Cool D; Kassam Z; Bastian-Jordan M; Gómez JA; Moussa M; Chin JL; Pautler S; Bauman GS; Ward AD
Brachytherapy; 2022; 21(4):435-441. PubMed ID: 35337747
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition.
Sachpazidis I; Mavroidis P; Zamboglou C; Klein CM; Grosu AL; Baltas D
Radiat Oncol; 2020 Oct; 15(1):242. PubMed ID: 33081804
[TBL] [Abstract][Full Text] [Related]
33. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway.
Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H
Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy.
Costa DN; Meng X; Tverye A; Bagrodia A; Recchimuzzi DZ; Xi Y; Arraj P; Shah RB; Subramanian N; de Leon AD; Roehrborn CG; Rofsky NM; Chen H; Pedrosa I
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):38-44. PubMed ID: 35995580
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
[TBL] [Abstract][Full Text] [Related]
36. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative.
Chandrasekar T; Denisenko A; Mico V; McPartland C; Shah Y; Mark JR; Lallas CD; Fonshell C; Danella J; Jacobs B; Lanchoney T; Raman JD; Tomaszewski J; Reese A; Singer EA; Ginzburg S; Smaldone M; Uzzo R; Guzzo TJ; Trabulsi EJ
Urol Oncol; 2023 Aug; 41(8):355.e1-355.e8. PubMed ID: 37357123
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.
Kauffmann G; Arif F; Patel P; Oto A; Liauw SL
Urol Oncol; 2018 Oct; 36(10):471.e11-471.e18. PubMed ID: 30122344
[TBL] [Abstract][Full Text] [Related]
39. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract][Full Text] [Related]
40. Findings in 1,123 Men with Preoperative
Raveenthiran S; Yaxley WJ; Franklin T; Coughlin G; Roberts M; Gianduzzo T; Kua B; Samaratunga H; Delahunt B; Egevad L; Wong D; McEwan L; Brown N; Parkinson R; Esler R; Yaxley JW
J Urol; 2022 Mar; 207(3):573-580. PubMed ID: 34694140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
